Huidan Huang

Dr. Huidan Huang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XQXiaqiu Qiu
Xiaqiu Qiu
YLYuanqing Li
Yuanqing Li
BYBin Yu
Bin Yu
JRJie Ren
Jie Ren
HHHuidan Huang
Huidan Huang
JBJinlei Bian
Jinlei Bian

2 January 2023 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
DWDanni Wang
Danni Wang
XLXiaohong Li
Xiaohong Li
GGGuangyue Gong
Guangyue Gong
YLYulong Lu
Yulong Lu
ZGZiming Guo
Ziming Guo
JBJinlei Bian
Jinlei Bian
The kidney-type glutaminase (GLS1), a key enzyme controlling the hydrolysis of glutamine to glutamate to resolve the ‘glutamine addiction’ of cancer cells, has been shown to play a central role in ...

22 March 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WWWei Wei
Wei Wei
QXQianqian Xu
Qianqian Xu
LWLiuyi Wu
Liuyi Wu
GGGuangyue Gong
Guangyue Gong
YTYucheng Tian
Yucheng Tian
ZLZhiyu Li
Zhiyu Li

23 August 2023 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
LZLi Zhu
Li Zhu
XCXiujin Chang
Xiujin Chang
SZShengpeng Zhang
Shengpeng Zhang
XBXiumei Bai
Xiumei Bai
AFAlexander V. Finko
Alexander V. Finko
HHHuidan Huang
Huidan Huang
Aim: A series of novel GLS1 irreversible allosteric inhibitors targeting Lys320 might have robust enzyme inhibitory activity and potent antitumor activity. Materials & methods: Novel GLS1 allosteri... Graphical abstract

27 March 2026 in ChemMedChem
Verified
Journal Article
Closed access
GZGang Zhao
Gang Zhao
JGJunyu Guo
Junyu Guo
XCXinying Cheng
Xinying Cheng
RWRenbing Wang
Renbing Wang
AAAhmed R. Ali
Ahmed R. Ali
HHHuidan Huang
Huidan Huang